Smith+Nephew Launches FLOW FLEXTEND COBLATION Wand
London, UK, August 17, 2026 Smith+Nephew, a global medical technology company, has announced the launch of its new FLOW...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
London, UK, August 17, 2026 Smith+Nephew, a global medical technology company, has announced the launch of its new FLOW...
TAMPA, Fla., July 16, 2026 PainTEQ has unveiled new scientific evidence supporting its cortical-piercing posterior sacroiliac (SI) joint fixation...
HERZLIYA, Israel, March 17, 2026 Regentis Biomaterials Ltd. has announced a breakthrough solvent-free manufacturing process for its lead regenerative...
HERZLIYA, Israel, January 29, 2026 — Regentis Biomaterials Ltd. announced a significant expansion of its U.S. clinical site network...
